M&A Analysis: Feeble Start To 2017
2017 kicked off with 12 medtech M&A acquisitions in January, a decline from the 18 M&A deals recorded in the same month last year, and two fewer than the previous month.
You may also be interested in...
Only a month after buying the tissue regeneration company Derma Sciences, Integra has announced a much larger acquisition for Codman Neurosurgery. The company says the buy would complement its current neurosurgery portfolio and boost its global reach.
The European Commission has approved Abbott Laboratories' pending acquisition of Alere, on condition that Alere's Epoc, Triage and BNP businesses are divested to alleviate anti-trust concerns. However, Abbott is still looking to cut loose from the $5.8bn deal.
Japan's Teijin is adding a family of bioresorbable, osteosynthetic bone-fixation devices to its modest but growing orthopedics portfolio.